Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × perflutren × Clear all

Phase

Phase 2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Letrozole 18 exemestane 11 Docetaxel 11 Anastrozole 11 Tamoxifen 9 Cyclophosphamide 9 Capecitabine 9 Zoledronic Acid 8 Paclitaxel 8 pegfilgrastim 7 Trastuzumab 7 Fulvestrant 7 Saline Solution 6 liposomal doxorubicin 5 Sodium Chloride 5 Epirubicin 5 Dexmedetomidine 5 Bupivacaine 5 Bevacizumab 5 palbociclib 4 abemaciclib 4 Tranexamic Acid 4 Filgrastim 4 trastuzumab deruxtecan 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3 ribociclib 3 pertuzumab 3 pegylated granulocyte colony-stimulating factor 3 eribulin 3 Standard of Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01490892 2025-05-06

Quantitative Subharmonic Breast Imaging

Thomas Jefferson University

Phase 4 Completed

219 enrolled 8 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡